全文获取类型
收费全文 | 18414篇 |
免费 | 1179篇 |
国内免费 | 89篇 |
学科分类
医药卫生 | 19682篇 |
出版年
2023年 | 128篇 |
2022年 | 111篇 |
2021年 | 467篇 |
2020年 | 355篇 |
2019年 | 424篇 |
2018年 | 537篇 |
2017年 | 436篇 |
2016年 | 587篇 |
2015年 | 661篇 |
2014年 | 804篇 |
2013年 | 1011篇 |
2012年 | 1579篇 |
2011年 | 1482篇 |
2010年 | 922篇 |
2009年 | 800篇 |
2008年 | 1316篇 |
2007年 | 1409篇 |
2006年 | 1304篇 |
2005年 | 1216篇 |
2004年 | 1093篇 |
2003年 | 991篇 |
2002年 | 873篇 |
2001年 | 168篇 |
2000年 | 99篇 |
1999年 | 152篇 |
1998年 | 133篇 |
1997年 | 114篇 |
1996年 | 58篇 |
1995年 | 50篇 |
1994年 | 41篇 |
1993年 | 44篇 |
1992年 | 43篇 |
1991年 | 22篇 |
1990年 | 20篇 |
1989年 | 20篇 |
1988年 | 24篇 |
1987年 | 14篇 |
1985年 | 8篇 |
1984年 | 11篇 |
1983年 | 7篇 |
1982年 | 15篇 |
1981年 | 7篇 |
1980年 | 10篇 |
1979年 | 6篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1974年 | 8篇 |
1973年 | 14篇 |
1970年 | 10篇 |
1966年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Matthias Barral Cynthia Pimpie Rachid Kaci Iman Al-Dybiat Massoud Mirshahi Marc Pocard Philippe Bonnin 《Ultrasound in medicine & biology》2021,47(3):759-768
The goal of the work described here was to assess the performance of Doppler ultrasound (US) of the superior mesenteric artery (SMA) and celiac trunk (CT) in the evaluation of tumor response in female mice with ovarian peritoneal carcinomatosis treated either with bevacizumab or with carboplatin. Compared with untreated mice, carboplatin-treated mice had a lower weight (23.3 ± 2.0 vs. 27.9 ± 2.9 g, p < 0.001), peritoneal carcinomatosis index (PCI, 11 ± 3 vs. 28 ± 6, p < 0.001), Ki67-positive staining surfaces (p < 0.001), vascular density (p < 0.001), mean blood flow velocity (mBFVel) in the SMA (7.0 ± 1.4 vs. 10.9 ± 1.8 cm/s, p < 0.001) and CT (8.0 ± 1.8 vs. 14.3 ± 4.6 cm/s, p < 0.001) and no ascites. Weight and mBFVel were similar in bevacizumab-treated and untreated mice. The mBFVels in the SMA and CT correlated with the PCI used as an estimation of the tumor burden, R = 0.70 (p < 0.0001) and R = 0.65 (p < 0.0001), respectively. Doppler US allows non-invasive assessment of the effects of anticancer therapy in ovarian peritoneal carcinomatosis-induced mice. 相似文献
2.
Matthias Knefel PhD Elisabeth L. Zeilinger PhD Simone Lubowitzki PhD Katharina Krammer MSc Matthias Unseld MD Rupert Bartsch MD Thorsten Fuereder MD Ulrich Jäger MD Barbara Kiesewetter MD Maria Krauth MD Markus Raderer MD Philipp B. Staber MD Peter Valent MD Alexander Gaiger MD 《Cancer》2023,129(21):3466-3475
Background
Survival in cancer patients is associated with a multitude of biological, social, and psychological factors. Although it is well established that all these factors add to overall mortality, it is not well understood how the predictive power of these parameters changes in a comprehensive model and over time.Methods
Patients who attended the authors’ outpatient clinic were invited to participate. The authors followed 5180 mixed cancer patients (51.1% female; mean age, 59.1 years [SD = 13.8]) for up to 16 years and analyzed biological (age, sex, cancer site, anemia), psychological (anxiety, depression), and social variables (marital status, education, employment status) potentially predicting overall survival in a Cox proportional hazards model.Results
The median survival time for the entire sample was 4.3 years (95% confidence interval, 4.0–4.7). The overall survival probabilities for 1 and 10 years were 76.8% and 38.0%, respectively. Following an empirical approach, the authors split the time interval into five periods: acute, subacute, short-term, medium-term, and long-term. A complex pattern of variables predicted overall survival differently in the five periods. Biological parameters were important throughout most of the time, social parameters were either time-independent predictors or tended to be more important in the longer term. Of the psychological parameters, only depression was a significant predictor and lost its predictive power in the long-term.Conclusions
The findings of this study allow the development of comprehensive patient-specific models of risk and resilience factors addressing biopsychosocial needs of cancer patients, paving the way for a personalized treatment plan that goes beyond biomedical cancer care. 相似文献3.
von Heesen Maximilian Schuld Jochen Hollnder Sebastian Spiliotis Antonios E. Merscher Anna Scherber Philipp R. Igna Dorian Gbelein Gereon Glanemann Matthias 《European Surgery》2022,54(6):317-325
European Surgery - The beneficial outcomes of hepatectomy in patients with colorectal metastases have encouraged the attempts of repeated hepatectomy in patients with recurrent disease. Although... 相似文献
4.
5.
6.
Kerstin Protz Joachim Dissemond Myriam Seifert Marianne Hintner Barbara Temme Ida Verheyen‐Cronau Matthias Augustin Marina Otten 《International wound journal》2019,16(6):1252-1262
Brochures are a useful supplement to patient education. There is increasing evidence that they are an effective medium to support patient satisfaction, adherence, and empowerment. This study aims to produce reliable data on how much patients with venous leg ulcer (VLU) may profit from a brochure that focuses on VLU and on measures and aims of the related compression therapy. The evaluation took part from October 2018 until March 2019 and included 136 patients with VLU and related compression therapy. They were randomly sorted into a case group and a control group of 68 patients each. The case group received a brochure about venous disease and compression therapy and filled in a questionnaire after reading. The questions ranged from basic knowledge about VLU and compression therapy to aspects of self‐care. The control group answered the same questions without previous reading of the brochure. The results show that in almost every aspect, the patients in the case group were better informed about their diseases, the compression therapy, and how they may support the measures adequately. This study suggests that patients with VLU may profit from a brochure that explains their disease and the related compression therapy. Better knowledge and understanding may strengthen their empowerment and adherence. 相似文献
7.
Research campaigns in the UK National Health Service: patient recruitment and questions of valuation
Matthias Wienroth Caroline Pearce Christopher McKevitt 《Sociology of health & illness》2019,41(7):1444-1461
The National Institute for Health Research (NIHR) aims to improve national ‘health and wealth' by providing infrastructural support to enable clinical research in National Health Service settings in England and Wales. Cognisant of the consequences of studies' failure to achieve required numbers of participants, it also actively campaigns to promote patient awareness of research, and willingness to participate in trials. In this paper, we analyse recent NIHR campaigns and policies designed to encourage patients to participate in clinical research to interrogate how they are implicated in the national bioeconomy. In doing so we expand the notion of ‘clinical labour' to include the work of patient recruitment and highlight an emergent obligation on patients to contribute to research processes. Whereas once patient knowledge and experience may have been devalued, here we draw on the concept of ‘assetisation' (Birch 2012) to explore the emergent relationship between healthcare system and patient as research participant. We consider how patients' contribution goes beyond the provision of standardised objects of valuation so that patients themselves may be perceived as assets to, not only recipients of, the national healthcare system. 相似文献
8.
9.
10.